Investigators designed and externally validated a prostate cancer death prediction model for risk stratification of men at the point of PSA screening.
NPM1-mutated AML prognosis was refined using a new genetic model integrating co-mutations, improving risk classification and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback